.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Cipla
Colorcon
Teva
Deloitte
McKinsey
Express Scripts
US Army
US Department of Justice

Generated: December 15, 2017

DrugPatentWatch Database Preview

RANITIDINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Ranitidine Hydrochloride patents expire, and what generic alternatives are available?

Ranitidine Hydrochloride is a drug marketed by Dr Reddys Labs Ltd, Mylan, Sandoz, Teva, Bedford, Mylan Labs Ltd, West-ward Pharms Int, Zydus Pharms Usa Inc, Actavis Mid Atlantic, Amneal Pharms, Apotex Inc, Aurobindo Pharma Ltd, Bio Pharm Inc, Breckenridge Pharm, Hi Tech Pharma, Nostrum Labs Inc, Pharm Assoc, Ranbaxy, Silarx, Taro, Tolmar, Vintage Pharms, Wockhardt, Amneal Pharms Ny, Apotex, Boehringer Ingelheim, Contract Pharmacal, Dr Reddys Labs Inc, Glenmark Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Perrigo, Perrigo R And D, Strides Pharma, Sun Pharm Inds Ltd, Watson Labs, and Watson Labs Inc. and is included in sixty-three NDAs.

The generic ingredient in RANITIDINE HYDROCHLORIDE is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. One hundred and forty suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ranitidine hydrochloride profile page.
Drug patent expirations by year for RANITIDINE HYDROCHLORIDE

Pharmacology for RANITIDINE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds LtdRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL075439-002Apr 19, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs IncRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL076705-001Jul 27, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
ApotexRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL074680-001Sep 12, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
WockhardtRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL078701-002Dec 11, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL075165-002Sep 30, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
RanbaxyRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL075254-001Jan 14, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms IncRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL078542-001Nov 19, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
MylanRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL075497-001Jan 14, 2000OTCNoNo► Subscribe► Subscribe► Subscribe
Par PharmRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL075180-001Jan 28, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
RanbaxyRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL075000-001Jan 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Deloitte
Mallinckrodt
Harvard Business School
Baxter
UBS
QuintilesIMS
Moodys
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot